Author

Nikita Aleksandrovich Kolesnikov

Research Institute of Medical Genetics of Russian Academy of Medical SciencesORCID 0000-0001-8855-577XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Research Focus:phylogenetics / evolution· 1 Approach:statistical model· 1

Frequent Co-Authors

Aitalina SukhomyasovaiD· 1 shared Andrey V. MarusiniD· 1 shared Anton MarkoviD· 1 shared I. Yu. KhitrinskayaiD· 1 shared M. G. SwarovskayaiD· 1 shared Natalia V. EkomasovaiD· 1 shared Olga Vladimirovna ShtygashevaiD· 1 shared Sergey LitvinoviD· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Aitalina SukhomyasovaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Structural variability, expression profile and pharmacogenetics properties of TMPRSS2 gene as a potential target for COVID-19 therapy

А. А. Зарубин, В. А. Степанов, Anton Markov, Nikita Aleksandrovich Kolesnikov, Andrey V. Marusin, I. Yu. Khitrinskaya, M. G. Swarovskaya, Sergey Litvinov, Natalia V. Ekomasova, Джаубермезов Мурат Алиевич, Н. Р. Максимова, Aitalina Sukhomyasova, Olga Vladimirovna Shtygasheva, Э. К. Хуснутдинова, М. О. Раджабов, Владимир Николаевич Харьков

The paper analyzes the structural variability, expression, and pharmacogenetics of the TMPRSS2 gene, identifying it as a potential target for COVID-19 therapy due to its role in SARS-CoV-2 priming and genetic diversity.

Genes · Dec 25, 2020Peer-reviewedGenomics